Astec LifeSciences Limited (NSE:ASTEC)
India flag India · Delayed Price · Currency is INR
556.30
+2.90 (0.52%)
Nov 17, 2026, 3:30 PM IST

Astec LifeSciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-795.77-809.18-1,348-469.3255.65898.59
Depreciation & Amortization
448.15444.98433.07358.17328.56336.55
Other Amortization
4.244.244.074.377.967.02
Loss (Gain) From Sale of Assets
1.240.66-20.181.115.24-0.14
Stock-Based Compensation
1.140.930.353.013.311.05
Provision & Write-off of Bad Debts
13.538.070.480.580.20.04
Other Operating Activities
341.25322.19580.4899.33204.71116.84
Change in Accounts Receivable
260.24-920.82188.84-135.121,216-836.83
Change in Inventory
7.02206.35158.68989.1-1,088-831.42
Change in Accounts Payable
134.5943.26-77.53-888.04-142.75607.15
Change in Other Net Operating Assets
196.41-107.75-4.71139-44.33-62.79
Operating Cash Flow
612.01-807.08-83.99102.21746.56236.04
Operating Cash Flow Growth
----86.31%216.28%-

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-38.27-55.36-218.22-1,355-1,173-1,040
Sale of Property, Plant & Equipment
5.447.0159.683.67.771.24
Other Investing Activities
58.735.296.24-0.4339.75-0.12
Investing Cash Flow
25.9-43.06-152.3-1,352-1,125-1,039

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-519.71100-1,277920.27
Long-Term Debt Issued
--1,6101,990586-
Total Debt Issued
519.71519.711,7101,9901,863920.27
Short-Term Debt Repaid
--100-269.55-40.12-830-
Long-Term Debt Repaid
--1,511-817.61-439.65-427-
Total Debt Repaid
-885.87-1,611-1,087-479.77-1,257-
Net Debt Issued (Repaid)
-366.16-1,091622.851,510606.48920.27
Issuance of Common Stock
-2,3620.020.791.312.99
Common Dividends Paid
----29.41-29.41-29.38
Other Financing Activities
-297.96-325.92-385.54-232.03-200.68-89.1
Financing Cash Flow
-666.9944.87237.331,250377.7804.78

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
-28.9994.741.04-0.02-0.812.16

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
573.74-862.44-302.21-1,253-426.03-803.74
Free Cash Flow Growth
------
Free Cash Flow Margin
13.07%-19.25%-7.93%-27.32%-6.78%-11.87%
Free Cash Flow Per Share
25.75-40.28-15.41-63.88-21.73-41.01
Levered Free Cash Flow
558.87-953.77-230.84-1,337-673.05-1,486
Unlevered Free Cash Flow
742.87-740.77-4.12-1,182-547.06-1,432

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
297.96325.92385.54232.03200.6889.1
Cash Income Tax Paid
1.36.01-49.9219.6548.9291.5
Change in Working Capital
598.25-778.96265.27104.94-59.06-1,124